Información de la publicación

Phase 1b study of isatuximab in combination with bortezomib, cyclophosphamide, and dexamethasone in newly diagnosed, transplant-ineligible multiple myeloma patients

Fuente: HemaSphere, 2023, 7(2), e829

Publisher: Wolters Kluwer Health

Year of publication: 2023

No. of pages: 5

Publication type: Article

ISSN: 2572-9241

Google Scholar

Citations

BRINGHEN, SARA

MARTINEZ-LOPEZ, JOAQUIN

SAN-MIGUEL, JESUS

OLIVA, STEFANIA

RODRIGUEZ-OTERO, PAULA

LE ROUX, NADIA

DONG, YVONNE

DOROUMIAN, SEVERINE

MACÉ, SANDRINE

MATEOS, MARIA-VICTORIA

Bib Ris